The US-Chinese company Adcentrx Therapeutics has raised $38m in a Series A+ round to begin a phase 1 trial of its lead candidate antibody-drug conjugate (ADC) later this year.
TRiSS Director celebrated at Trinity Innovation Awards - Trinity Research in Social Sciences (TRiSS) tcd.ie - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tcd.ie Daily Mail and Mail on Sunday newspapers.
Chinese synthetic biology firm Bluepha announced today that it has completed a B3 round of financing, bringing total round-B funds to 1.5 billion yuan ($235 million).